In 2012, biotechnology and drug companies have been all over the news. So many stocks surged in the last six months based on clinical trial results, FDA approval, FDA advisory committee recommendation, European commission approval, recommendation from independent committees, partnerships with big pharmaceuticals, acquisitions, and so on. Below is a list of biotechnology companies that have huge upside – or downside – potential in the month of August:
1.) Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (SNY)
Dug Name: ZALTRAP; PDUFA Date: August 4, 2012
2.) Talon Therapeutics, Inc 9 (TLON.OB)
Drug Name: Marqibo; PDUFA Date: August 12, 2012
3.) Gilead Sciences Inc (GILD)
Drug Name: Quad; PDUFA Date: August 27, 2012
4.) Delcath Systems, Inc (DCTH)
Drug Name: CHEMOSAT; NDA Filing Date: mid-August 2012